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Members of the genus Brucella are pathogenic bacteria exceedingly well adapted to their
hosts. The bacterium is transmitted by direct contact within the same host species or
accidentally to secondary hosts, such as humans. Human brucellosis is strongly linked
to the management of domesticated animals and ingestion of their products. Since the
domestication of ungulates and dogs in the Fertile Crescent and Asia in 12000 and 33000
ya, respectively, a steady supply of well adapted emergent Brucella pathogens causing
zoonotic disease has been provided. Likewise, anthropogenic modiﬁcation of wild life
may have also impacted host susceptibility and Brucella selection. Domestication and
human inﬂuence on wild life animals are not neutral phenomena. Consequently, Brucella
organisms have followed their hosts’ fate and have been selected under conditions that
favor high transmission rate. The “arm race” between Brucella and their preferred hosts
has been driven by genetic adaptation of the bacterium confronted with the evolving
immune defenses of the host. Management conditions, such as clustering, selection,
culling, and vaccination ofBrucella preferred hosts have profound inﬂuences in the outcome
of brucellosis and in the selection of Brucella organisms. Countries that have controlled
brucellosis systematically used reliable smooth live vaccines, consistent immunization
protocols, adequate diagnostic tests, broad vaccination coverage and sustained removal
of the infected animals. To ignore and misuse tools and strategies already available for
the control of brucellosis may promote the emergence of new Brucella variants. The
unrestricted use of low-efﬁcacy vaccines may promote a “false sense of security” and
works towards selection of Brucella with higher virulence and transmission potential.
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INTRODUCTION
Brucellosis is a vicious disease caused by facultative intracellu-
lar extracellular pathogens of the genus Brucella (Moreno and
Moriyón, 2002). The bacterium preferentially replicates within
phagocytic cells of the reticuloendothelial system, and in the
pregnant animal, inside placental trophoblasts. In domesticated
animals, brucellosis is mainly manifested by abortion and epi-
didymitis. Under natural conditions, Brucella is horizontally or
vertically transmitted. Horizontal transmission occurs through
close contact from host to host by means of secretions, sex-
ual intercourse, and more commonly, through liking of aborted
fetuses (Figure 1). Although Brucella has been observed to sur-
vive for some time in open environments, the bacterium hardly
divides and eventually dies (Crawford et al., 1990). Likewise, some
vectors have sporadically been implicated in brucellosis trans-
mission (Gudoshnik, 1958; Dawson et al., 2008; Neglia et al.,
2013). However, neither of these two last events plays a signiﬁ-
cant role in the transmission of brucellosis and they are not of
epidemiological relevance (Meyer, 1977; Moreno and Moriyón,
2006).
In humans, the disease is more severe than in domestic
animals, displaying a collection of clinical symptoms (Dalrymple-
Champneys, 1960; Pedro-Pons et al., 1968; Figure 2). While there
are a few reports of vertical and horizontal transmission between
humans (Meltzer et al., 2010; Wyatt, 2010), these are rare events.
Therefore, brucellosis in humans is strongly linked to the man-
agement of infected animals and ingestion of unpasteurized dairy
products (Moreno and Moriyón, 2006; Figure 1). In this regard,
there is a clear connection of brucellosis with the domestication of
even-toed ungulates, milking practices, and fabrication of cheese
and other dairy products. It is, therefore, not accidental that
lactase persistence – a genetic trait that allows adults to digest
lactose from raw milk – has been traced to ungulate domestica-
tion places (Sahi, 1994; Enattah et al., 2008; Itan et al., 2010) and
in course with the persistence of brucellosis in ancient pastoral
people.
At no other time in human history have the changes in tech-
nology, domestication and environment been more rapid and so
extreme. For thousands of years humans have created new ways
of living and social actions have emerged to minimize the effects
of infectious diseases. However, domestication and clustering of
wild life reservoirs with narrower genetic backgrounds have pro-
vided a steady supply of emergent pathogenic organisms. In this
regard, brucellosis constitutes an utmost example of a how animal
pathogens can emerge as public and veterinary health problems.
Here I review how humans have fostered the illness we now call
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FIGURE 1 | Brucella (B. abortus) life host cycle. After host infection the
invading Brucella replicates within cells of the reticuloendothelial system
where it remains for a protracted period of time. After pregnancy, the
bacterium invades trophoblasts and the mammary gland. In these sites the
bacterium extensively replicates inducing abortion and shedding through
milk (black arrows). The heavy contaminated placenta and fetus become the
main source of infection for humans and other animal hosts (blue arrows).
Humans may acquire the bacterium through ingestion of unpasteurized
dairy products. Brucella may live up to several weeks, as long as enough
organic material is available and the bacterium is protected from the sun’s
rays. When exposed to sun’s rays in the open, Brucella organisms steadily
die (doted black arrow). Pasteurization or fermentation of dairy products
eliminates Brucella organisms and the risk of human contamination (red
blunt arrows). Cross contamination of wild life animals (e.g., bison at lower
right) may maintain the bacteria cycling within wild herds, and then of
epidemiological relevance. Humans and other animals (e.g., horses) are
considered dead ends for the bacterium, and therefore there are not of
epidemiological relevance.
brucellosis that has accompanied civilization since ancient times,
when the malady was recognized by its main symptoms: abortion
and fever.
THE DISCOVERY OF Brucella AND BRUCELLOSIS
The seminal discovery of the causative agent of brucellosis,“Micro-
coccus melitensis” (later named Brucella melitensis), by the British
Surgeon Captain David Bruce, his wife Mary Elizabeth Steele
and theMaltesemicrobiologist doctorGiuseppeCaruana-Scicluna
has been eagerly described in many assays (Spink, 1956; Ruiz-
Castañeda, 1986; Wyatt, 2000, 2009a). These scientists isolated the
bacterium from the liver of diseased soldiers in the Mediterranean
island of Malta in 1887, a country that holds prominentmegalithic
constructions beyond 7000 years old. Following this discovery,
the Maltese medical doctor Fioravanti Temistocle Archimede Lau-
renzo Giuseppe Sammut, better known as “Temi Zammit,” found
that the causative agent of Malta fever, Mediterranean fever,
Cyprus fever, Neapolitan fever, Gibraltar fever, Crimean fever,
Cartagena fever, Rock fever, Barcelonan fever, Corps disease, and
undulant fever – just to mention a few names used for this vicious
malady – was transmitted from infected goats to humans through
contaminated milk (Wyatt, 2005, 2011). Thereafter, Surgeon Cap-
tain M. Louis Hughes and Captain James Crawford Kennedy
discovered signiﬁcant details on the zoonotic transmission of
brucellosis, including venereal transmission in both humans and
animals (Wyatt, 2009b).
Ten years after the isolation of M. melitensis, the Danish sci-
entist Bernhard Bag identiﬁed “Bacillus abortus” (later named
Brucella abortus) in bovine aborted fetuses (Bang, 1897). Traum
(1914) reported the isolation of another organism related to
M. melitensis (later assigned as Brucella suis) from aborted pigs
in United States. But the ﬁnal link of these zoonotic bacteria
was accomplished in 1918 by the outstanding American micro-
biologist Alice Catherine Evans (Evans, 1918). Her achievements
helped to understand the epidemiology of brucellosis and con-
tributed to the founding of milk pasteurization as preventive
measure. Then, in 1920, Louis Meyer and Wilbur Shaw honored
David Bruce and proposed to group these pathogenic bacte-
ria within a single genus named Brucella (Meyer and Shaw,
1920).
The events that followed all these inspiring investigations have
demonstrated the existence of different Brucella species (Figure 3)
that cause brucellosis in domestic animals (cows, sheep, goats,
pigs, camels, reindeer, and dogs), wild land animals (bison,
elk, hares, muskox, caribou, foxes, and several rodents) and
sea mammals (dolphin, whales, seals, and walruses; Godfroid
et al., 2011; Guzmán-Verri et al., 2012). Despite of this diver-
sity the only species that are linked to human brucellosis are
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FIGURE 2 | Brucellosis in humans. (A) The bar graphic displays the most
frequent 34 signs of brucellosis recorded in 1500 patients with proved
disease (adapted from Dalrymple-Champneys, 1960). (B) The clinical chart
displays the typical “undulant fever” suffered by one patient with
subsequent clinical signs of brucellosis (adapted from Pedro-Pons et al.,
1968). (C) Human brucellosis cases and bovines displaying positive Brucella
infections in United States during 13 year lapse period (1976–1986; adapted
from Nicoletti, 1989). In contrast to the silent course of brucellosis in
non-pregnant domestic animals, brucellosis in humans courses with a
broad collection of clinical symptoms. Notice that the increase and
decrease of human brucellosis cases roughly correlates with the increase
or decrease of the infection in cattle.
B. melitensis, B. suis, B. abortus, and to minor extent Brucella
canis (Moreno and Moriyón, 2006); this last specie being the
causative agent of canine brucellosis (Carmichael and Bruner,
1968). Apart from this group there are other Brucella strains (e.g.,
B. inopinata) that have been rarely isolated fromhumans (McDon-
ald et al., 2006; De et al., 2008; Scholz et al., 2010); however, no
connection between zoonotic transmission and disease has been
established.
Members of the genus Brucella are phyllogenetically related
to α-Proteobacteria that live in close association with animal
and plant cells (Moreno and Moriyón, 2002). From the geno-
typic perspective the genus is monophyletic with DNA similarity
above 97% (Verger et al., 1985). In spite of this, Brucella species
can be distinguished by single-nucleotide polymorphism anal-
ysis, host preference and conspicuous differences in virulence
(Bosseray et al., 1982; Foster et al., 2012). In addition, there are
several straight forward phenotypic differences, being the most
obvious the absence of surface O-polysaccharide chain in nat-
urally occurring rough species such as B. canis and Brucella
ovis (Moreno and Moriyón, 2006). One interesting feature of
the genus is the absence of plasmids and lysogenic phages, a
phenomenon that precludes the horizontal transference of genes
through classical routes (Moreno, 1998). Based on this, it has been
proposed that the extant Brucella species expand clonally within
the host environment and that genetic drift depends almost exclu-
sively on mutation and internal genetic rearrangements (Moreno,
1998).
Brucellosis is one of the few diseases in which efﬁcient live
bacterial vaccines (e.g., B. abortus S19 and B. melitensis Rev1)
have been developed (Cotton et al., 1933; Elberg and Meyer,
1958). Likewise, through history of microbiology very few dis-
eases have more diagnostic tests than brucellosis (Moreno and
Moriyón, 2006). As expected, the isolation of the bacterium stands
as the gold standard. However, simple techniques, such as the
Rose Bengal test, have survived all challenges and are the most
wildly used serological assays (Díaz et al., 2011). This is not by
chance, since by the combination of immunization with smooth
vaccines, Rose Bengal serological diagnosis and culling of the
animals, brucellosis has been controlled and eradicated in many
countries of the world (Davidson, 1970; Crawford and Hidalgo,
1977; Whittem, 1978; Wise, 1980; Chamberlin, 1985; Crawford
et al., 1990).
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FIGURE 3 | Dispersion of Brucella species confronted to the phylogeny of
their preferred host mammal.The dispersion of the various Brucella species
is depicted as cones proportional to the number of strains analyzed. The
numbers in the mammal phylogenetic tree represent millions of years. B. suis
biovar 2 also has afﬁnity for hares (lagomorphos). B. ceti Hum (human type)
does not correspond phylogenetically to B. ceti group and this single isolate
requires taxonomic deﬁnition. The source of the two isolates of B. inopinata is
unknown. Notice that phylogenetic relationship between the two clades is
not perfect suggesting that carnivore mammals acquire brucellosis (probably
by depredation) after the initial dispersion of cetaceans and ungulates from an
ancestral mesonychid, close to 65–60 million ya. Phylogenetic dendrogram
was adapted from Guzmán-Verri et al. (2012).
THE EMERGENCE OF ZOONOTIC BRUCELLOSIS
Through coordinated measures, brucellosis was ﬁnally eradicated
from the island of Malta 90 years after the discovery of the disease
(Wyatt, 2009a). Unfortunately, this has not been the fate of other
areas around the Mediterranean Sea, mainly in African, eastern
Mediterranean, and Middle East countries, where the disease has
been endemic for thousands of years and from which brucellosis
was spread around the world (Figure 4).
ZOONOTIC BRUCELLOSIS IN EURASIA AND MIDDLE EAST
Analogous to the island of Malta, Butrint inAlbania keeps valuable
World Heritage Sites that give testimony on the existence of pas-
toral inhabitants for millennia (Ryder, 1981). Pathological studies
andDNA analysis performed in human remains from graves dated
1260–1020 ya, revealed the presence of Brucella as the causative
agent of the disease that affected these Middle Age inhabitants in
the ancient city of Butrint (Mutolo et al., 2012). In addition to
Albania, other Balkans countries such as Macedonia and Bosnia
and Herzegovina still struggle with animal and human brucellosis;
a phenomenon that was boosted by the decline of veterinary and
health services in these countries during the political and armed
conﬂicts in the 1990s (Bosilkovski et al., 2010; Puto et al., 2010;
Ahmetagic et al., 2012). Human brucellosis outbreaks have also
thrived in Balkan neighboring countries such as Greece, Italy, and
Turkey (Minas et al., 2007; Mancini et al., 2013). Most likely the
disease was endemic in these Mediterranean counties since the
beginning of civilization (D’Anastasio et al., 2011). Remains of
cheese buried in Pompeii and Herculaneum have been associ-
ated with the transmission of brucellosis in Roman imperial times
(Capasso, 2002). Likewise, a critical analysis of Thucydides’history
regarding the plague of Athens (2430–2420 ya) suggests the pres-
ence brucellosis (Kousoulis et al., 2012). Archeological evidence
from 7000 ya in the eastern Mediterranean region of Anatolia
demonstrated ancient skills to transport milk and to manufacture
yogurt and cheese, all vehicles for brucellosis contagion (Evershed
et al., 2008).
Presumptive human brucellosis cases in skeletal remains from
the Bronze Age (4100–3550 ya) have been found in Palestine and
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FIGURE 4 |Timeline of events associated with zoonotic brucellosis.The scale increases logarithmically from 5 million years in the past to 50 years
estimated as the “present” (in 1950). Dates are designated as indicated in the main text.
Jordan (Capasso, 2002; D’Anastasio et al., 2011). It is not coin-
cidental that these places are close to the Fertile Crescent and
Taurus Mountains, sites where sheep, goats, cows, and pigs – all
known to be preferred Brucella hosts – were domesticated between
12000 and 10000 ya (Nelson, 1998; Naderi et al., 2008; Pariset
et al., 2011; Bonﬁglio et al., 2012). Brucellosis has been also impli-
cated in Bronze Age sites located in Bahrain, Persian Gulf (Rashidi
et al., 2001; D’Anastasio et al., 2011). This archipelago belongs to
a region where the dromedary camel – another common Brucella
host – was domesticated about 6000 ya (Peters, 1997). In this area,
human brucellosis acquired through the ingestion of camel dairy
products is still endemic, mainly in semi-nomadic Bedouin popu-
lations (Rafai, 2002; Shimol et al., 2012). Analyses of human DNA
remains from 5000 to 4500 ya have revealed that late Neolithic
Europeans displayed lower frequency of lactase persistence than
modern extant populations (Plantinga et al., 2012). This is com-
patible with evolutionary pressures related to the consumption of
rawmilk and consequentlywith higher chances to become infected
with Brucella.
Brucellosis is highly prevalent in Asia (Zhang et al., 2010;
Denisov et al., 2013; Li et al., 2013). Paleopathological evidence
indicates that Lapp people in the Artic area of Northern Eura-
sia domesticated reindeer (the preferred host for B. suis biovar 4)
3000–2000 ya or even earlier (Røed et al., 2011; van Kolfschoten
et al., 2011) and that these inhabitants also suffered from brucel-
losis (Ortner, 2003; Røed et al., 2011). Bovine and swine were
already present in China, Mongolia, and Korea, at least 5000 ya
or even before, shortly after their domestication in the Fertile
Crescent (Nelson, 1998; Giuffra et al., 2000; Zhang et al., 2013).
It seems that water buffalo (Bubalus spp.) was also domesticated
in China about 4000 ya (Teasdale and Bradley, 2012). However,
milk and derived dairy products are not commonly found in East
Asian cuisines, a culinary activity that is compatible by the lactose
intolerance distribution in these populations (Itan et al., 2010).
Two exceptions are human groups living in the Asian steppes and
Mongolia who still consume milk and fermented dairy products;
then keeping lactose tolerance and human brucellosis. It is likely
that brucellosis was endemic in these areas before imperial times.
ZOONOTIC BRUCELLOSIS IN AFRICA AND INDIAN SUBCONTINENT
Humanbrucellosis is highly prevalent in India (Mantur andAmar-
nath, 2008). Bovine Bos indicus zebu breeds were domesticated in
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the Indus Valley region (today Pakistan) about 7000 ya (Teasdale
and Bradley, 2012). An independent domestication of water buf-
falo was achieved in India about 5000 ya (Kumar et al., 2007).
Infected water buffalos shed Brucella in the milk; however, these
animals are more resistant to Brucella induced abortion than Bos
species (Borriello et al., 2006; Adams and Schutta, 2010). An inde-
pendent domestication of goats also occurred in the Indus Basin
in Pakistan already 9000 ya (Joshi et al., 2004). Considering these
events, it is striking that up to 80% of the Indian population is
lactose intolerant. It has beendetermined that themutation for lac-
tose tolerance was introduced later on to eastward India from the
MiddleEast (GallegoRomero et al., 2012). This suggests that inges-
tion of dairy products started later in India than in other regions,
and with it, zoonotic brucellosis. Another alternative comes from
how Indians prepare their milk: they often ferment it in the form
of lassi or paneers, processes that break down the lactose and also
kills Brucella organisms.
Human brucellosis was described in Mediterranean African
countries more than 100 ya (Rafai, 2002). It is likely that bru-
cellosis was present in human settlements in Northern Africa
already 3000 ya and highly prevalent in Egypt during biblical
times (e.g., OT, Isaiah 37:8–9, and 2 Kings 19:8–9). Studies per-
formed inEgyptian archeological sites dated750B.C. have revealed
several human hip bones with signs of brucellosis in this region
(Hodgkins, 2002). Brucellosis in southern Africa was detected in
dairy herds as early 1913 and the ﬁrst human cases in 1921 (Bevan,
1931). It seems that the introduction of Indian and Eurasian
bovine, sheep, and goat breeds into Africa occurred rapidly after
their domestication in the Fertile Crescent. Nevertheless, it has
been established that different African ethnic groups have distinct
lactase gene mutations that arose independently in different loca-
tions between 6800 and 2700 ya (Tishkoff et al., 2007). These data
ﬁts well with archeological evidence suggesting that pastoral peo-
ples reached eastern Africa in different migration waves, about
4500–3500 ya.
It is feasible that brucellosis existed in indigenous African
Artiodactyla species (which include a signiﬁcant number of poten-
tial Brucella hosts) long before the introduction of domesticated
herds. A paleopathological study has suggested the presence of
Brucella infections in australopithecines, already 2.5–2.3-million
ya (D’Anastasio et al., 2009, 2011). As expected, this proposal
not only has implications on the origin of the disease in local
African fauna but, remarkably, also on the feeding habits of these
human ancestors. In spite of this, it seems that Brucella infec-
tions in indigenous African mammals remain low (Gomo et al.,
2012) and only relevant when wildlife ungulates become in con-
tact with infected domesticated cows, goats, or sheep (Madsen and
Anderson, 1995).
INTRODUCTION OF ZOONOTIC BRUCELLOSIS IN THE AMERICAN
CONTINENT AND OCEANIA
The only indigenous Brucella specie in the American Continent
seems to be Brucella neotomae, ﬁrst isolated in United States
from desert wood rats in 1957 (Stoenner and Lackman, 1957).
B. neotomae is conﬁned to these rodents with no other known
hosts. The absence of domesticated ungulate reservoirs before
European colonization very likely circumvented the presence of
zoonotic brucellosis in the New World. This is revealed by the
close to 100% lactose intolerance of adult Amerindians and in
Inuit people (Alzate et al., 1969; Ellestad-Sayed et al., 1978; Sahi,
1994). Thus, it is unlikely that American inhabitants – who
populated the continent between 12000 and 4000 ya – ingested
milk from potential Brucella infected wild life ungulates such as
bison, muskox, elk, or caribou. Therefore, the various zoonotic
Brucella species were likely introduced in America during the
last decade of the ﬁfteenth century by the ﬁrst Spaniards con-
querors following the arrival of cattle in the colonies (Bowling,
1942). At that time brucellosis was probably highly endemic in the
Iberian Peninsula. This is supported by the discovery of human
remains from the late Middle Ages displaying pathological signs
of brucellosis (Etxeberria, 1994) and by the description of the dis-
ease in Spain. For instance the clinical description of the “lousy
fever” suffered by the mystic poet St. Teresa of Jesus – born 20
years after Christopher Columbus opened up the Western Hemi-
sphere to European colonization – is compatible with brucellosis
(Senra-Valera, 2006).
As for other infectious diseases, the spreading of brucellosis
from the “Old World” to the “New World” very likely was a sig-
niﬁcant outcome of the conquests. It has been well documented
that during his second voyage to the American Continent in 1493,
Christopher Columbus introduced a signiﬁcant number of cattle
and pigs (de las Casas, 1951). Very probably by these means the
introduction of brucellosis in the continent, including the con-
tamination of indigenous fauna such as bison (Rhyan et al., 2013).
Brucellosis was detected in a Yellowstone American buffalo herd
already in 1917 (Mohler, 1917). Until the ﬁrst half of the twentieth
century, European cows shared with bison herds the same pasture
lands (Bowling, 1942) making likely cross infection (Figure 1).
Indeed, brucellosis in North American bison and elk has been
related to cross contamination of bacterial strains (including vac-
cine strains) from infected European bovine breeds (Meagher and
Meyer, 1994; Higgins et al., 2012). Furthermore, the same B. abor-
tus biovars (1 and 2) are found in both classes of bovine herds.
The disease in the American buffalo is similar to that of domesti-
cated cattle (Rhyan et al., 2001b); though it is believed that bison,
like water buffalo,may display some resistance to Brucella induced
abortion (Herman, 2013).
The origin of B. suis biovar 4 infecting Canadian and Alaskan
caribou and muskox has been traced to imported reindeer from
Siberia, early in the twentieth century (Meyer, 1966; Forbes,
1991). Domesticated reindeer should be also considered a poten-
tial source of zoonotic disease since brucellosis – caused by B. suis
biovar 4 – has been found in Eskimos (Davies and Hanson, 1965;
Meyer, 1966; Forbes, 1991). Alternatively, B. suis biovar 4 could
have arrivedwith infected caribou andmuskox through the Bering
Land Bridge during the last glaciation (Campos et al., 2010; Røed
et al., 2011).
Human brucellosis was prevalent in Mexico, USA, and Canada
for centuries (Spink, 1956;Wise, 1980; Ruiz-Castañeda, 1986). The
ﬁrst human cases in NorthAmerica were recognized between 1889
and 1894 (Craig, 1903; Gentry and Ferenbaugh, 1911). With the
exception of Mexico, nowadays the presence of human brucellosis
has become a rare event in northern hemisphere of the American
continent. This was the result of the successful pasteurization of
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dairy products and the application of control programs based in
extensive immunization of herds with smooth Brucella vaccines,
diagnostic tests such as Rose Bengal and complement ﬁxation and
efﬁcient culling and management of animal ﬂocks during the sec-
ond half of the twentieth century (Crawford and Hidalgo, 1977;
Wise, 1980). In contrast, the absence of coordinated control pro-
grams, poor management of animal ﬂocks, and the introduction
of vaccines with low efﬁcacy have kept brucellosis highly prevalent
in Mexico, Central America, and most South American countries
(Moreno, 2002; Vargas, 2002; Lucero et al., 2008; Herrera-López
et al., 2010; Godfroid et al., 2011; Aznar et al., 2012; Román et al.,
2013; Rubach et al., 2013).
Brucella canis – the last Brucella zoonotic specie described –was
discovered in SouthernUnited States in the late 1960s (Carmichael
and Bruner, 1968). Dogs were the ﬁrst animals to be domesticated
in the world. The earliest archeological vestiges are from Siberia
dated 33000 ya; while in the American continent the oldest known
ancient remains date 11000 ya (Leonard et al., 2002; Ovodov et al.,
2011). Then, it was expected to ﬁnd B. canis in dog’s wild relatives.
However, there are no reports of B. canis in wolf or coyote packs
and these wild canines seem to display some resistance to smooth
Brucella species (Davis et al., 1988; Tessaro and Forbes, 2004). Nev-
ertheless, it seems feasible that B. canis evolved in dog’s ancestor
after predation of B. suis biovar 4 infected hosts in Asia (e.g., cari-
bou/reindeer), since these two brucellae species are closely related
(Figure 3). Moreover, wolves and Artic foxes can become nat-
urally infected with rangiferine brucellosis (Neiland, 1975). As
other zoonotic brucellae, B. canis might have penetrated to the
American Continent during the European colonization. Alterna-
tively, B. canis could have traveled in infected dogs through the
Bering Strait already 12000 ya (Leonard et al., 2002). Presently,
canine brucellosis has spread throughout the American Continent
(Hollett, 2006; Tuemmers et al., 2013). In any case, the zoonotic
potential of B. canis is low and just sporadic human cases have
been reported in the world (Lucero et al., 2008).
Human and animal brucellosis were very important diseases in
New Zealand and Australia as these countries keep large numbers
of sheep and bovines. As expected, lactose intolerance occurrence
in indigenous people from Oceania is above 95% (Enattah et al.,
2008; Itan et al., 2010), a fact that agrees with the absence of indige-
nous large mammal animals in this region. It is therefore likely
that human brucellosis stared with the arrival of infected domes-
tic livestock to Oceania lands in the eighteenth century, through
“The First Fleet” and in the ships commanded by Capitan Cook
(Gillen et al., 1989). Before this, the only placental mammals (and
potential Brucella hosts) in Australia were bats, some indigenous
rats, mice, and the feral dog named “dingo” introduced from Asia
5000 ya (Ardalan et al., 2012). In New Zealand the only placen-
tal mammals were bats, kiore rats and the Polynesian dog named
kurı−.
Bovine brucellosis was ﬁrst recorded in New Zealand in 1893
and eradicated 106 years later by an aggressive program that
included S19 vaccination, testing, and slaughter of the infected
herds (Davidson, 1970). A comparable control program was
followed by Australia with a great success (Whittem, 1978; Cham-
berlin,1985). Theﬁrst cases of ramepididymitis causedbyBrucella
ovis were recorded in New Zealand in 1953 (Buddle, 1956). Since
B. ovis is not pathogenic for humans or other species of ani-
mals and mainly affects rams, there are no clear historical records
regarding this disease before its discovery. In addition, Brucella
strains have been isolated in rodents and foxes in Australia (Tiller
et al., 2010a; Al Dahouk et al., 2012) and two unconventional Bru-
cella strains (one in Australia and one in New Zealand) have been
detected in humans (McDonald et al., 2006; Tiller et al., 2010b).
In spite of this, no links with the transmission from animals
to humans has been established in these cases. Canine brucel-
losis has just been recently found in domestic dogs in Australia
(Gardner and Reichel, 1997; Hofer et al., 2012) but never reported
in dingo or kurı− dogs. Presently, human and animal brucel-
losis are just sporadic in Australia and New Zealand, remaining
feral pigs as the only source of human infections (Eales et al.,
2010).
ARTIFICIAL SELECTION OF Brucella
Pathogens and hosts evolve in response to each other and the
genetic diversity of both parties represents a pool of possible vari-
ants to maintain adaptation via natural selection (Ewald, 2004).
Thus, the “arm race” between Brucella and preferred hosts has
been driven by genetic adaptation of the bacterium virulent sys-
tems confronted with the evolving immune defenses of the host.
Domestication, anthropogenic modiﬁcation of wild life and selec-
tion of animals by humans are not neutral phenomena. In each
event a concomitant selection of the parasitic microbiota occurs
(Pearce-Duvet, 2006). Consequently, it is expected that the preva-
lent extant Brucella strains have been selected through “narrow
funnels” connected to these processes.
Brucella SELECTION THROUGH DOMESTICATION OF ANIMALS
It does not seem by chance that the most virulent Brucella species
with higher zoonotic spectrum are those from domesticated ani-
mals; while those that display lower pathogenicity and zoonotic
potential are those from wild life animals (Figure 5). Reports
of human infections from wildlife reservoirs are scarce. More-
over, within the zoonotic brucellae there are some species that
are more virulent than others (e.g., B. melitensis > B. suis bio-
vars 1, 3, and 4 ≥ B. abortus > B. canis; Spink, 1956; Bosseray
et al., 1982; Ruiz-Castañeda, 1986; Caron et al., 1994). In contrast,
Brucella ceti and Brucella pinnipedialis preferentially infecting
free living cetaceans and pinnipeds, respectively, have seldom
been found in other animal groups and their zoonotic poten-
tial and overall virulence for other animal species, including
bovine and swine, seem low (Rhyan et al., 2001a; Perrett et al.,
2004; Bingham et al., 2008; Guzmán-Verri et al., 2012). Likewise,
Brucella species and strains (e.g., B. neotomae, B. microti, and
B. suis biovar 5) having preference for wild land mammals are
conﬁned to their natural hosts and seldom found in domestic ani-
mals or humans (Moreno and Moriyón, 2006; Al Dahouk et al.,
2012). Therefore, it is expected that the most prevalent viru-
lent Brucella strains were selected during the domestication of
animals.
The selection of Brucella towards lower or higher virulence
has been demonstrated experimentally. Through mutagenesis of
genes coding for the so called virulent determinants or regulatory
molecules Brucella may become attenuated (González et al., 2008;
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FIGURE 5 | Zoonotic and non-zoonotic Brucella species.The most
virulent species with higher zoonotic spectrum are those from
domesticated animals; while those displaying lower pathogenicity and
zoonotic potential are those from wild life animals. One exception is B. ovis
which is a pathogen for rams and does not infect other hosts.
Barrio et al., 2009;Wang et al., 2012). Likewise, bymeans of genetic
manipulation or selection through serial passages into animals,
Brucella strains can become robust pathogens (Gibby and Gibby,
1965; Jiménez de Bagüés et al., 2010; Grilló et al., 2012; Terwagne
et al., 2013).
In addition of displaying host preferences, the various Bru-
cella species and strains also form genetic groups that relate with
distinctive geographic origins (Le Flèche et al., 2006; Foster et al.,
2012; Garofolo et al., 2013; Jiang et al., 2013; Di et al., 2014). This
means that Brucella clones rapidly expand and transmit within
domesticated groups of animals. In spite of their high DNA sim-
ilarity, the various bacterial species and strains are selected and
form discrete family clusters. These observations parallel those
showing that some Brucella strains may have been removed or
minimized from the bacterial pool as consequence of the con-
trol programs. Indeed, several B. abortus biotypes described
decades ago (Crawford et al., 1990; Meyer, 1990) have not been
isolated for more than 40 years; instead, predominant variants
remain in bovine herds. Therefore, it is feasible that Brucella
selection towards higher transmissibility and replication occurs
through successive infections in conﬁned hosts, as proposed for
the evolution of other diseases (Ewald, 2004).
One exception is B. ovis (Figure 5). Although this bacterium
may have been also subjected to selection processes during the
domestication of sheep, it remains non-pathogenic for humans or
for other animals (Blasco, 1990). In general, rough brucellae such
as B. ovis are less virulent than their smooth counterparts and
have narrower ability to infect other hosts (Moreno and Moriyón,
2006; González et al., 2008). It may be that B. ovis was already
selected towards a higher afﬁnity for venereal transmission in
sheep before domestication of ovine, as suggested before (Moreno,
1992). Moreover, the basal “deep” phylogenetic location of B. ovis
in relation to B. abortus, B. melitensis, B. suis, and B. canis clusters
(Foster et al., 2012), also suggests earlier adaptation of B. ovis to
its host.
HERD SIZE AND POPULATION DENSITY IN THE SELECTION OF Brucella
Other trend that has favored the prevalence and dissemination of
brucellosis corresponds to the intensive exploitation of productive
animals (Crawford et al., 1990). Humans have taken advantage of
the innate social behavior of ungulates and canines and clustered
them in small areas. In addition, following anthropocentric pur-
poses, the genetic background of these domestic animals has been
narrowed. As in other infectious disease, lower genetic diversity
and crowded effect may favor transmission and select for faster
replicating organisms with major zoonotic potential (McDaniel
et al., 2013). Examples of these were observed in the early days
of brucellosis in Malta (Wyatt, 2005, 2009a), and more recently
in foodborne outbreaks in Peru (Román et al., 2013) and massive
outbreaks in Inner Mongolia, threatening hundreds of thousands
of people.
Inner Mongolia, which keeps the largest sheep population
(18.2% of the ﬂock), also ranks ﬁrst in animal and human brucel-
losis in China (Pu et al., 2009; Mi et al., 2010; Zhang et al., 2010).
In 2007, new brucellosis cases were reported in 85 out of 102 dis-
tricts in Inner Mongolia, with positive prevalence remaining in
the other 47 districts. From 1996 to 2010, 78246 human cases were
detected with 90% of the new cases reported between 2005 and
2010. This accounts for 40% of the near 200000 cases detected in
China for this period. In 2010, this ﬁgure reached 47.2%. Accord-
ing to various models, this may be just the “tip of the iceberg”
and it is expected that the number of human cases will increase
dramatically in the following years (Hou et al., 2013). Moreover,
it has been demonstrated that in endemic areas about 20% of the
infected individuals remain undiagnosed. Indeed, family mem-
bers of the patients with brucellosis are under increased risk of
acquiring the disease (Tabak et al., 2008). Thus, family screening
in endemic areas is recommended.
Novel circumstances for fast transmission of zoonotic brucel-
losis have also been observed in conﬁned semi-nomadic Bedouins
infected from camel’s milk (Shimol et al., 2012; Shemesh and
Yagupsky, 2013) and commercial dog kennels. Camels cohabit-
ing with goats and sheep in small areas are becoming a common
practice in Middle East and Arab countries. Dog packs seldom
exceed more than a dozen individuals. Consequently, in crowded
kennels B. canis spreads rapidly inducing massive abortions in
bitches, testicular degeneration in males, and becomes a zoonotic
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risk (Lucero et al., 2008; Gyuranecz et al., 2011; Reynes et al.,
2012; Marzetti et al., 2013). Therefore, intensive exploitation and
clustering of animals in poor epidemiological control conditions
may favor selection for faster Brucella transmission and zoonotic
disease.
SELECTION OF Brucella IN WILDLIFE ANIMALS
Distinct Brucella clusters have also been identiﬁed in wild life
animal populations located in areas separated by natural barriers
(Forbes, 1991; Maquart et al., 2009; Guzmán-Verri et al., 2012). As
with domesticated species, anthropogenicmodiﬁcation of wild life
may also have narrowed the genetic diversity, impact host suscep-
tibility and pathogen transmission. A noteworthy event has been
the threatening of the American buffalo which was close to extinc-
tion (Hornaday, 1889). Thus, the prevailing bison herds have been
founded by a small group of few surviving individuals (Gross and
Wang, 2005). This is relevant since North American bison herds
remain infected with B. abortus (Rhyan et al., 2001b). The Euro-
pean counterpart of this incident corresponds to the Alpine ibex
(Capra ibex). Historically these wild goats were endemic through-
out the European Alps. Due to excessive hunting and constrain
of their natural habitat, the ibex herds in Central Europe declined
to low dangerous numbers. As consequence, the founding of new
ibex herds in the Alps come from a pool of few animals, narrow-
ing their genetic diversity (Biebach and Keller, 2009). In certain
areas ibex herds are infected with B. melitensis strains displaying
also high seroprevalence (Ferroglio et al., 1998; Mick et al., 2014).
Therefore, these wild goats may become a source for the reintro-
duction of B. melitensis in domestic ruminants and humans in
Central Europe (Mailles et al., 2012; Hars et al., 2013; Rautureau
et al., 2013).
Another example relates to the hunting of marine mammals,
linked to the overexploitation of their natural food resources and
contamination of the seas. These negative activities have pro-
moted clustering of different Brucella infected marine mammals
in reduced areas where food is available, causing excessive com-
petition, undernutrition, stress, and immunosuppression (Ohishi
et al., 2008; Van Bressem et al., 2009). As revealed by the increasing
brucellosis case reports in some species of cetaceans over others
(Maquart et al., 2009; Guzmán-Verri et al., 2012), these unnatu-
ral conditions may favor the selection of Brucella organisms with
higher transmission rate.
Brucella divergence seems linked to selective forces within the
host environment, and consequently, to the evolution of the host
(Moreno, 1998). However, this constrain is not absolute and Bru-
cella species living in wild life or in semi-domesticated hosts may
still qualify as potentially pathogens for humans and domestic
animals (Godfroid et al., 2011). The phenotypes of B. ceti, B. pin-
nipedialis, B. microti, and B. neotomae correspond to smooth types
equipped with all known “virulent” factors (Audic et al., 2009;
Guzmán-Verri et al., 2012). Up to now “mysterious” subtle dif-
ferences with the classical zoonotic Brucella have kept these other
wildlife species out from causing disease in humans. But the cor-
relation of the various species in relation to host preference is
not perfect and phylogenic patters suggest that Brucella organisms
are capable to breakdown the species barrier and “jump” from
one mammal order to a very differ one (Figure 3). Eventually,
this might favor the persistence of a distinct Brucella clone in a
different “preferred” host.
COPING WITH BRUCELLOSIS
In the presence of brucellosis, management becomes highly
demanding (Spink, 1956; Ruiz-Castañeda, 1986; Moreno and
Moriyón, 2006). Domesticated animals and humans have coex-
isted for millennia without signiﬁcant intervention measures to
control the disease. It is likely that a large part of the prevalent
Brucella zoonotic species was selected in ﬂocks during this long-
lasting initial period. In some regions of the world, mainly in
low income countries, these weak control actions are still com-
mon (Rubach et al., 2013). It is likely that a fraction of the genetic
background of both humans and animals has been also shaped
during the coexistence with Brucella organisms; mainly nearby to
the regions where domestication took place (Pashaei et al., 2009;
Asaei et al., 2013; Rasouli et al., 2013).
ERADICATING BRUCELLOSIS
After the discovery of Brucella organisms and their mode of
transmission, direct measures toward the control and eradica-
tion of the disease were taken in several countries. As stated,
killing of the bacterium by milk heating was one of the ﬁrst
procedures that prevented the transmission of brucellosis. A
second relevant action was the discovery of diagnostic tech-
niques capable to distinguish infected animals (Alton et al., 1988).
Third, was the development of efﬁcient vaccines for protecting
bovine, caprine, and ovine herds (Cotton et al., 1933; Elberg and
Meyer, 1958). In addition, in some areas systematic slaughter-
ing of the infected animals reduced the density of the bacterium
(Ebel et al., 2008). Though, the control of brucellosis by the
sole action of culling the infected animals is extremely expen-
sive and not practical under high disease prevalence conditions
(Moreno, 2002; Ofﬁce International des Épizooties, 2013). Fol-
lowing this, massive vaccination in combination with serological
diagnoses and culling of the infected animals has become the
chief strategy for the control of brucellosis (Ofﬁce International
des Épizooties, 2013). Countries where brucellosis has effec-
tively been controlled have used the following procedures: reliable
live vaccines (e.g., S19 and Rev1), adequate immunization pro-
tocols (e.g., single dose vaccination, reduced dose), extensive
protection coverage (e.g., 100% of the herds at risk), suitable
diagnostic tests (e.g., Rose Bengal, RID, Complement ﬁxation,
iELISA), sustained removal of the infected animals and restric-
tion in the trafﬁc of animals from infected herds to free herds
(e.g., control transhumance herds; Davidson, 1970; Whittem,
1978; Wise, 1980; Moreno and Moriyón, 2006; Ebel et al., 2008).
Accordingly, these countries have also narrowed the genetic
pool of virulent brucellae and succeeded in eradicating human
brucellosis.
THE BASIC REPRODUCTIVE NUMBER AND SELECTION OF VIRULENCE
THROUGH VACCINATION
The basic reproductive number, also known as R0, is the average
number of secondary infections arising from one infected indi-
vidual in a completely susceptible animal population (Gandon
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et al., 2001). That is, for the disease to spread and for an effec-
tive animal to animal Brucella transmission it is required that
the pathogen’s R0 exceeds 1 (Figure 6). In contrast if R0 < 1,
then the disease has the tendency to fade away. Higher the
R0 value, higher will be the number of subsequently infected
individuals. Concomitantly, larger and denser the population
of susceptible individuals higher would be the chances for the
pathogen to achieve a steady and successful adaptation in the
host. As consequence of a collection of unsuccessful events in
many middle and low income countries (Moreno, 2002; Blasco
and Moriyón, 2005), the R0 value exceeds 1; thus keeping the
disease and the zoonotic potential high (Vargas, 2002; God-
froid et al., 2011; Aznar et al., 2012; Chand and Chhabra, 2013;
Denisov et al., 2013; Jiang et al., 2013; Li et al., 2013; Rubach et al.,
2013).
Yet, brucellosis is a complex disease and signiﬁcant political
and economic interests are often in play (Moreno, 2002; Pappas
and Memish, 2007; Lundquist, 2012). Of all the problems in con-
trol programs, the introduction of low protection rate vaccines
stands as a major drawback (Blasco et al., 1993; Verger et al., 1995;
Moriyón et al., 2004; Godfroid et al., 2011). Apart from their fail-
ure in controlling brucellosis, there are long-term consequences
in the use vaccines with low efﬁcacy. In this direction a variety of
evolutionary scenarios are possible (Gandon et al., 2001; Gandon
and Day, 2007), including the selection of more virulent Brucella
strains.
Effective vaccination limits Brucella infection, restricts shed-
ding, hampers transmission fromanimal to animal anddiminishes
the risk of zoonosis (Nicoletti, 1990). In addition, when combined
with removal of positive infected animals, efﬁcient vaccination
may select for breeds with higher resistance against the disease
(Adams and Schutta, 2010). Immunization with efﬁcient vaccines
may replace natural infections by inducing competent immunity
(Plommet et al., 1987); likewise, culling of the infected animals
replaces the natural selection of hosts displaying reproduction
impartments, such abortion, placenta retention, and infertility
(Fogel and Fogel, 2011). Eventually, these sustained combined
strategies establish a R0 < 1 with the concomitant peter out of
the disease. Moreover, when R0 < 1 the pathogen evolution rate
towards higher virulence may be overcome and virulent ﬁeld Bru-
cella strains eradicated from domestic ﬂocks (Davidson, 1970;
Whittem, 1978; Wise, 1980; Moreno and Moriyón, 2006; Ofﬁce
International des Épizooties, 2013).
In contrast, inefﬁcient vaccines currently used in many coun-
tries for the control of bovine, sheep, or caprine brucellosis might
work in the opposite direction. Indeed, the protection afforded
FIGURE 6 | Herd immunity theory and the basic reproductive ratio (R0)
in Brucella herd infections. Herd immunity theory proposes that the
protective effect of Brucella vaccinated individuals in a given population
extends beyond to unvaccinated population. R0 corresponds to the average
number of new Brucella infections caused by single infected source. If
acquired immunity is present in the herd, the population is no longer
entirely susceptible. The greater the proportion of individuals is immune to
Brucella, the smaller the probability that a susceptible host will come into
contact with an infectious animal. Then, the transmission from one animal
to other is likely to be disrupted when an appropriate number of the
population (predicted on the basis of R0) are immune to the bacterium. For
instance, if R0 = 2 (an estimated R0 for B. melitensis transmission in
sheep), then a geometric increase in infections occurs over time (right
panel). If 75% of the population is protected by the vaccine (minimal
protection rate estimated for Rev1 vaccine), then the bacteria fails to grow
in the host animal and be transmitted (left panel). It is predicted that
vaccines with lower protection rate require larger coverture and greater
actions of culling of the animals. New productive infections are depicted by
black solid arrows; unproductive transmission is indicated by dashed blunt
arrows.
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to non-immune animals by the presence of sufﬁcient numbers
of immune individuals, known as “herd immunity” (Figure 6) is
threatened if the immune status of the herd is low. That is, inef-
ﬁcient vaccines may promote a fertile niche in weakly immune
hosts allowing virulent Brucella to be transmitted though vacci-
nated animals (Herrera-López et al., 2010,2011;Arellano-Reynoso
et al., 2013). In curse this will increase the number of secondary
infections. For example, if the anti-Brucella vaccine fails to gener-
ate immunity in a fraction p of those animals vaccinated, then to
achieve herd immunity we need to vaccinate a proportion of indi-
viduals equivalent toR0 − 1/R0(1− p) (Figure 7). Hence, if p is too
big it may be impossible to eradicate brucellosis as it has been the
case in many countries where vaccines of low-efﬁcacy have exten-
sively been used (Blasco et al., 1993; Moreno, 2002; Vargas, 2002;
Blasco and Moriyón, 2005; Arellano-Reynoso et al., 2013; Chand
and Chhabra, 2013; Denisov et al., 2013; Hou et al., 2013; Jiang
et al., 2013; Li et al., 2013; Oseguera-Montiel et al., 2013; Rubach
et al., 2013).
In cases in which the relative ﬁtness of competing pathogens
depends on the immune status of their host, low-efﬁcacy vac-
cines inducing responses below the protective threshold may also
prompt pathogen evolution towards higher virulence (Figure 8;
Read and Mackinnon, 2008). Selection pressures may work in
the same direction observed for non-sterilizing antibiotic treat-
ments, in which the surviving microbes may display a higher
resistance edge (Davies and Davies, 2010). Furthermore, anti-
Brucella vaccines lacking some fundamental virulent molecular
determinants or displaying a large collection of mutations (Wang
et al., 2012), give a competitive advantage to virulent strains pos-
sessing full set of these factors, as it has been already shown
for rough Brucella strains devoid of O-polysaccharide antigen
(González et al., 2008; Barrio et al., 2009; Herrera-López et al.,
2010).
ANTI-Brucella VACCINES AND A FALSE SENSE OF SECURITY
In certain contexts vaccination induces a “sense of security” in
non-specialized general public. This sense of security is sustained
in the trust and faith that people have developed on vaccines
that successfully prevented and eradicated diseases. If the vac-
cine is highly efﬁcient, then the faith and trust is justiﬁed and
not harm is done. However, this complacency is particularly dan-
gerous when vaccines with low efﬁcacy and short-term protective
duration are introduced; then, a “false sense of security” may be
generated, mainly when the information is not given properly
(Henderson et al., 2011). Generally speaking, the false sense of
security lays between the optimal expected efﬁcacy for a given
vaccine and the real performance of that vaccine (Figure 8) and it
has a direct impact in the assessment of herd immunity. The use
of anti-Brucella vaccines displaying low efﬁcacy could generate a
false sense of security in the minds of livestock farmers and Vet-
erinary Health authorities, who may believe that herds are fully
protected.
Under low threshold immunity conditions the host becomes
a favorable environment for the replication and spread of ﬁeld
bacterial strains (Moreno, 2002; Herrera-López et al., 2010, 2011;
Arellano-Reynoso et al., 2013; Denisov et al., 2013; Jiang et al.,
2013) and a potential niche for Brucella selection. This is
FIGURE 7 | Sceneries for vaccine performances against brucellosis
according to various models. (A) Predicted model for bovine brucellosis
eradication in Mato Grosso (blue), Rodôni (red), and Goiás (black) Brazilian
States with different experimental prevalences using two vaccine
protection rates. Protection rate by low-efﬁcacy vaccines or low coverage
vaccination are not capable to eradicate brucellosis in four decades (solid
lines), independently of the initial prevalence. The critical threshold applies
to both: (i) the proportion of the population that needs to be vaccinated,
and; (ii) the protective quality of the vaccine (adapted from Amaku et al.,
2009). (B) Prediction for the elimination or persistence or of brucellosis
according to R0 and the critical level of vaccination V c. The V c needed to
protect a given population of animals is calculated by V c = 1 − 1/R0. Those
vaccines that fail to generate immunity in a fraction p of the immunized
individuals, require higher coverage deﬁned by R0 − 1/R0(1 − p). However,
if p is too big it may be impossible to eradicate the Brucella infection.
Parameters such as culling of the infected animals and diminishing of the
density of the susceptible animals have a signiﬁcant impact in both (A) and
(B) since by reducing the value of p (not shown). The solid black line
represents the outcome of an ideal no “leaking” vaccine (adapted from
Keeling et al., 2013).
particularly relevant when prevalence is high and surveillance is
low to begin with and when the favored virulent microbe emerges
within a restricted population. These arguments are supported by
several mathematical and epidemiological models (Gandon et al.,
2001; Scherer and McLean, 2002; Day and Gandon, 2007; Gandon
and Day, 2007).
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FIGURE 8 | Prediction for emergence of resistant-vaccine Brucella
strains and the false sense of security. (A) Immunization with low
efﬁcacy vaccines may change the competitive balance between Brucella
virulent strains. Before vaccination (6–8 months of age) one prevalent strain
is observed (blue line). After vaccination of 100% of the susceptible animals
with a low efﬁcacy vaccine that only gives 30–40% protection rate, the
vaccine-resistant strain (red line) may eventually emerge with a competitive
advantage that is only evident after a large proportion of the population has
been vaccinated over the years. The vaccine resistant-strain arises from the
Brucella pool, either through mutation of the prevalent strain or by selection
of previously existing strains. Only after the R0 of the vaccine-resistant
strain has exceeded that of the prevalent strain, then a new brucellosis
epidemic event develops. Solid blue and red lines correspond to the
prevalence ordinate; dashed lines correspond to the R0 ordinate (adapted
from Scherer and McLean, 2002). (B) Reduction in brucellosis prevalence
below the critical vaccination threshold (expected vaccine performance)
with an anti-Brucella vaccine efﬁcacy of 75% and R0 = 4. In a bovine close
homogeneous population a lower value for R0 would be associated with a
lower Brucella prevalence. The false sense of security (shadow area) for a
given vaccine lays between the expected vaccine performance (e.g., 75%)
and the real vaccine performance (e.g., 50%).
ANTIBIOTICS AND Brucella
In the light of unrestricted use of antibiotics the emergence of
antibiotic resistant Brucella clones should not be excluded a pri-
ori. However, in contrast to other bacterial pathogens, antibiotics
do not seem to play a signiﬁcant selective role in brucellosis. Due
to economical, epidemiological, and public health reasons, treat-
ment with antibiotics has been precluded in productive animals
with brucellosis (Guerra and Nicoletti, 1986; Radwan et al., 1993;
Ofﬁce International des Épizooties, 2013). One exception is canine
brucellosis. Pets with brucellosis are frequently treatedwith antibi-
otics, not always with success (Ledbetter et al., 2009). Antibiotics
have also been used in brucellosis research for selecting speciﬁc
strains displaying antibiotic resistance (Schurig et al., 1991; Adone
et al., 2005; Ravanel et al., 2009), This has also important impli-
cations in the accidental transmission of Brucella organisms in
the laboratory and the potential role of this bacterium as biolog-
ical weapon (Yagupsky and Baron, 2005). In spite of this, most
Brucella clinical isolates remain susceptible to the classical antibi-
otics used for treatment of brucellosis (Guerra and Nicoletti, 1986;
Ayas¸lıog˘lu et al., 2008; Maves et al., 2011; Abdel-Maksoud et al.,
2012). In broad terms, people constitute a dead end for Bru-
cella transmission (Spink, 1956; Ruiz-Castañeda, 1986); therefore,
antibiotic treatment of infected humans is not epidemiologically
relevant (Figure 1). This phenomenon may relate to the absence
of plasmids and lysogenic phages in Brucella organisms, as it
has been explained elsewhere (Moreno, 1998). In this sense, the
short-term emergence of antibiotic resistant Brucella does seem
plausible.
CONCLUDING REMARKS
The capabilities of Brucella to infect and propagate in the preferred
hosts follow at least ﬁve stages: (i) ability to invade; (ii) power to
circumvent the initial defenses; (iii) competence to replicate; (iv)
capacity to be transmitted; and (v) endurance to be maintained
within the host population (Moreno and Moriyón, 2006; Mar-
tirosyan et al., 2011). How, when, and where pathogens cross the
boundaries that separate their natural hosts from human popu-
lations and provoke an epidemic disease, is not entirely known.
Human-to-human Brucella transmission would require that the
pathogen’s R0 exceeds 1 (Gandon et al., 2001). Although Brucella
animal pathogens have already achieved the ﬁrst three stages in
humans and in occasions the fourth stage (Meltzer et al., 2010),
still the disease in humans is terminal and human mediated
transmission is not of epidemiological importance (Figure 1).
Thus, Brucella has not yet reached the R0 threshold to emerge
as permanent pathogen within human populations and conta-
gion remains dependent on animal reservoirs. However, under
these circumstances human brucellosis may display a R0 above
the threshold that depends on the zoonotic infection rate. For
instance, as consequence of high prevalence in domestic ani-
mal reservoirs (sheep) in Inner Mongolia, the R0 for human
infection corresponds to 1.8 (Hou et al., 2013). Under the pre-
vailing control measures and use of low protective vaccines
(Blasco et al., 1993; Verger et al., 1995) it was predicted that
human brucellosis will continue to increase for the next decade
in China.
Ecological factors and human activities may inﬂuence and
induce changes in the microbial virulence patterns. But to dis-
tinguish Brucella clones displaying higher virulence is not an easy
task (Moreno and Moriyón, 2002). Brucella organisms lack classi-
cal molecular markers commonly used to trace virulence such as
toxins, ﬁmbria, plasmids, capsules, antigenic variation or resistant
forms. The so called “virulent factors” are intertwined with the
overall Brucella structure and physiology (Moreno and Moriyón,
2002; Barbier et al., 2011) and are found in practically all Bru-
cella species examined, independently of their pathogenicity for
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humans (Audic et al., 2009, 2011). Moreover, many of the molec-
ular determinants such as cell envelope components, secretion
systems, regulatory systems, transporters, and effectors assigned
as virulent factors are also found in soil bacteria related to bru-
cellae (Barquero-Calvo et al., 2009). As stated before, Brucella
species form a compact genetic cluster and display host preference
commensurate with their phylogenetic dispersion (Maquart et al.,
2009; Audic et al., 2011; Foster et al., 2012). Therefore, the major
scientiﬁc challenges that brucellosis research confronts relate to the
identiﬁcation of those discrete genotypic and phenotypic changes
that have favored the adaptation to the preferred hosts and those
molecular determinants that have made some Brucella species
more virulent than others. In addition, efﬁcient vaccines for dogs,
pigs,water buffalo, and camels, aswell as for somewild life animals,
are required (Godfroid et al., 2011).
During the ﬁrst half of the twentieth century through the early
1980s, efﬁcient live Brucella S19 and Rev 1 vaccines for prevent-
ing brucellosis were developed together with robust procedures
for testing their safety and efﬁcacy (Cotton et al., 1933; Elberg
and Meyer, 1958; Crawford and Hidalgo, 1977; Alton et al., 1988;
Moreno and Moriyón, 2006). In addition, various inexpensive
and straightforward serological tests as well as good management
strategies were successfully implemented (Crawford and Hidalgo,
1977; Alton et al., 1988). Those were the days when brucellosis
control programs succeeded in many parts of the world (Crawford
and Hidalgo, 1977; Plommet, 1992). Circumstances have changed
and the global agenda has been modiﬁed towards other inter-
ests. Taking into account that ignorance persists and economic
proﬁts pursue without other considerations, it is difﬁcult to envi-
sion what will happen and how biological and cultural evolution
will shape brucellosis and human battlement against this zoonotic
disease.
For much of the twentieth century the misuse of antibi-
otics has taken place with little concern on the evolutionary
consequences and selection of antibiotic resistance hypervir-
ulent bacterial strains (Davies and Davies, 2010). It is our
contention that we should not repeat that complacency with
misuse of poor brucellosis vaccines, dubious immunization pro-
tocols, expensive diagnostic tests, and inadequate management
procedures.
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